Drug Trends has identified, crawled (or ‘scraped’), extracted, categorised and analysed drug listings on cryptomarkets on a regular basis since 1st February 2014. This bulletin series reports on trends in the availability and types of drugs sold on the internet via cryptomarkets over a 12-month (a new bulletin is typically released every 4 months). The current bulletin focuses on analysis of drug listings on cryptomarkets from October 2022 to September 2023.

An accompanying public online interactive data visualisation is available, allowing viewers to interact with data collected over the total monitoring period.

Key findings

From 1st October 2022 to 30th September 2023, 18 cryptomarkets were monitored, of which 11 remained active at the end of the reporting period.
The four markets reaching more than 10,000 listings in a snapshot during this period were DarkFox, Bohemia, AlphaBay and ASAP.
In the final month of monitoring, Bohemia, Tor2Door, Incognito and Nemesis were the largest cryptomarkets.
There was an average of 38,698 drug listings per snapshot in September 2023, with an estimated decrease in listings of -7.9% per month as compared to October 2022 (n=77,090).
Cannabis comprised the greatest percentage of drug listings from October 2022 to September 2023 (31%), followed by MDMA (7.7%), benzodiazepines (7.5%), cocaine (7.4%), opioids (excluding heroin) (6.0%), and meth/amphetamine (illicit) (5.7%).
The market share of ketamine showed the highest rate of increase from 3.8% in October 2022 to 5.0% in September 2023. Significant decrease in market share was observed for cannabis, PIEDs/weight loss drugs and NPS in the 12-month period.

Recommended citation

Man N, Yang Y, Sadaphale V, Linghu Q, Bruno R, Barratt MJ, Sutherland R, Peacock A. Trends in the availability and type of drugs sold on the internet via cryptomarkets, October 2022 - September 2023. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2023. Available from: doi.org/10.26190/rrwd-2g43

Funding and copyright

Drug Trends is supported by funding from the Australian Government Department of Health and Aged Care under the Drug and Alcohol Program.

©NDARC, UNSW SYDNEY 2023

This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. All other rights are reserved. Requests and enquiries concerning reproduction and rights should be addressed to the information manager, NDARC, UNSW Sydney, NSW 2052, Australia via drugtrends@unsw.edu.au.

Date published

23 Nov 2023

Resource type

Drugs and New Technologies (DNeT) bulletins